Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance

This publication has 56 references indexed in Scilit:

• Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
  Endocrine Reviews, 2008
• Altered Adipose and Plasma Sphingolipid Metabolism in Obesity
  Diabetes, 2006
• In vitro evidence that hyperglycemia stimulates tumor necrosis factor-α release in obese women with polycystic ovary syndrome
  Journal of Endocrinology, 2006
• Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes
  American Journal of Physiology-Endocrinology and Metabolism, 2004
• Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes
  International Journal of Obesity, 2003
• Inhibition of Akt Kinase by Cell-permeable Ceramide and Its Implications for Ceramide-induced Apoptosis
  Published by Elsevier ,1998
• Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH
  Journal of Biological Chemistry, 1998
• The urine from patients with peritonitis as a rich source for purifying human acid sphingomyelinase and other lysosomal enzymes
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
• Metabolism of sphingomyelin in the intestinal tract of the rat
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968
• A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
  Canadian Journal of Biochemistry and Physiology, 1959